clobetasol propionate · Harrow Eye · NDA 218158
Byqlovi
Earliest generic entry, as listed
9 May 2036
Blocked by patent: US 10588913, US 11376262.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10588913 | product | 9 May 2036 |
| US 11376262 | product, use U-19 | 9 May 2036 |
Exclusivities · 1 unexpired
| NP | new product | 4 Mar 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 218158 · 001 · RLD | suspension/drops, ophthalmic | 0.05% | 9 May 2036 |